Apellis Pharmaceuticals Inc banner

Apellis Pharmaceuticals Inc
F:1JK

Watchlist Manager
Apellis Pharmaceuticals Inc Logo
Apellis Pharmaceuticals Inc
F:1JK
Watchlist
Price: 34.68 EUR 0.76%
Market Cap: €4.2B

Intrinsic Value

The intrinsic value for Apellis Pharmaceuticals Inc (1JK) under the Base Case is 29.49 EUR. Compared with the current market price of 34.68 EUR, the stock appears Overvalued by 15% .

Based on two methods:

DCF suggests overvaluation, while multiples suggest undervaluation.

1JK Intrinsic Value
29.49 EUR
Overvaluation 15%
Intrinsic Value
Price €34.68
Base Case Scenario
Monitor 1JK
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value €23.59
Get notified when the price drops into your buy zone
Current Price €34.68
Intrinsic Value €29.49
Margin of Safety 20% €23.59
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation History
Ask AI Assistant
What other research platforms think about 1JK?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is 1JK valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Apellis Pharmaceuticals Inc.

Explain Valuation
Alternatives to 1JK

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

APLS Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one 1JK stock?

The intrinsic value for Apellis Pharmaceuticals Inc (1JK) under the Base Case is 29.49 EUR.

Is 1JK stock undervalued or overvalued?

Compared with the current market price of 34.68 EUR, the stock appears Overvalued by 15% .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett